AZTA,RGEN Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

Dollar change -0.37
Percentage change -0.81	%

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJH VTI VB VBR VXF MDY DFAT ROBO SCHA DFSV

Index	-	P/E	-	EPS (ttm)	-2.97	Insider Own	2.59%	Shs Outstand	48.92M	Perf Week	8.79%
Market Cap	2.19B	Forward P/E	66.58	EPS next Y	0.68	Insider Trans	2.23%	Shs Float	47.65M	Perf Month	10.63%
Income	-164.17M	PEG	-	EPS next Q	0.05	Inst Own	102.11%	Short Float	9.12%	Perf Quarter	-8.91%
Sales	656.32M	P/S	3.34	EPS this Y	-6.10%	Inst Trans	-10.17%	Short Ratio	7.12	Perf Half Y	-11.35%
Book/sh	38.82	P/B	1.16	EPS next Y	76.19%	ROA	-6.59%	Short Interest	4.34M	Perf Year	-21.26%
Cash/sh	9.57	P/C	4.72	EPS next 5Y	12.00%	ROE	-7.63%	52W Range	38.82 - 69.16	Perf YTD	-30.67%
Dividend Est.	-	P/FCF	53.53	EPS past 5Y	-	ROI	-8.98%	52W High	-34.70%	Beta	1.49
Dividend TTM	-	Quick Ratio	3.50	Sales past 5Y	2.06%	Gross Margin	38.07%	52W Low	16.33%	ATR (14)	2.30
Dividend Ex-Date	Dec 02, 2021	Current Ratio	4.07	EPS Y/Y TTM	-1327.16%	Oper. Margin	-11.11%	RSI (14)	53.81	Volatility	5.20% 4.93%
Employees	3500	Debt/Eq	0.03	Sales Y/Y TTM	-1.32%	Profit Margin	-25.01%	Recom	3.00	Target Price	48.40
Option/Short	Yes / Yes	LT Debt/Eq	0.03	EPS Q/Q	-283.54%	Payout	-	Rel Volume	16.41	Prev Close	45.53
Sales Surprise	0.24%	EPS Surprise	75.61%	Sales Q/Q	-1.33%	Earnings	Nov 12 AMC	Avg Volume	610.38K	Price	45.16
SMA20	3.45%	SMA50	-0.13%	SMA200	-14.48%	Trades		Volume	10,015,198	Change	-0.81%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
04:05PM	Loading…
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
04:05PM	Loading…
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-01-24 04:15PM	Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report (PR Newswire)
04:05PM	Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-12-24 08:00AM	Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum (PR Newswire)
Feb-08-24 10:53AM	Azenta, Inc. (NASDAQ:AZTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 05:02PM	Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 (GuruFocus.com)
04:05PM	Loading…
04:05PM	Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 (PR Newswire)
Feb-02-24 08:00AM	Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management (PR Newswire)
Jan-25-24 04:05PM	Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-11-24 04:05PM	Azenta to Host Investor Day on March 14, 2024 (PR Newswire)
Jan-09-24 04:05PM	Azenta to Participate in the 26th Annual Needham Growth Conference (PR Newswire)
Jan-03-24 04:05PM	Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Nov-21-23 04:05PM	Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-23 01:06PM	Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.89%
Nov-13-23 05:04PM	Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure (GuruFocus.com)
04:07PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023 (PR Newswire)
04:06PM	Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation (PR Newswire)
04:05PM	Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project (PR Newswire)
Nov-10-23 04:05PM	Azenta to Participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-23 04:05PM	Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-19-23 04:05PM	Azenta to Host GENEWIZ Week November 6-10, 2023 (PR Newswire)
Sep-26-23 08:00AM	Azenta Announces CFO Transition (PR Newswire)
Sep-08-23 04:05PM	Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Sep-07-23 04:05PM	Azenta to Participate in the Baird 2023 Global Healthcare Conference (PR Newswire)
Aug-10-23 08:00AM	Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (PR Newswire)
Aug-09-23 04:05PM	Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference (PR Newswire) +20.33%
12:00PM	Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70% (Simply Wall St.)
Aug-08-23 04:05PM	Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 (PR Newswire)
Aug-03-23 04:05PM	Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jun-29-23 04:05PM	Azenta Announces New Biorepository in the Greater Boston Area (PR Newswire)
Jun-21-23 08:00PM	AZTA: Lowering target price to $36.00 (Argus Research)
May-31-23 10:24AM	Vazyme Signs Global Strategic Cooperation Agreement with Azenta (PR Newswire)
May-30-23 04:05PM	Azenta to Participate in the Jefferies Healthcare Conference (PR Newswire)
May-24-23 08:00AM	Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery (PR Newswire)
May-17-23 04:05PM	Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference (PR Newswire) +5.53%
May-09-23 04:05PM	Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment (PR Newswire) -18.89%
May-03-23 04:05PM	Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-26-23 08:00PM	AZTA: Lowering target price to $43.00 (Argus Research)
Apr-13-23 07:00PM	Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-15-23 05:06PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (PR Newswire)
Mar-07-23 04:15PM	Azenta Publishes its Environmental, Social, & Governance (ESG) Report (PR Newswire)
Feb-28-23 04:05PM	Azenta to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-27-23 07:30AM	Azenta Launches Cryo Store Pico, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications (PR Newswire)
Feb-10-23 07:30AM	Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (PR Newswire)
Feb-08-23 04:05PM	Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022 (PR Newswire) -18.29%
Feb-06-23 04:35PM	Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Feb-03-23 07:00AM	Azenta Announces the Acquisition of Ziath (PR Newswire)
Jan-23-23 09:00AM	Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors (GlobeNewswire)
Jan-05-23 08:00AM	Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
07:55AM	Azenta to participate in the 25th Annual Needham Growth Conference (PR Newswire)
Dec-22-22 11:21AM	Should You Consider Azenta (AZTA) for Investment? (Insider Monkey)
Nov-23-22 07:15AM	Azenta Announces $500 Million Accelerated Share Repurchase Agreement (PR Newswire)
Nov-21-22 04:05PM	Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-22 04:10PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program (PR Newswire) +21.83%
04:09PM	Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors (PR Newswire)
Nov-09-22 08:30AM	Azenta to participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-22 04:52PM	Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg (PR Newswire)
Nov-07-22 04:38PM	Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-03-22 04:05PM	Azenta Announces Completion of B Medical Systems Acquisition (PR Newswire)
Sep-28-22 04:00PM	ETFs: Investing in automation has become the latest 'mega-trend,' expert explains (Yahoo Finance Video)
Sep-06-22 04:05PM	Azenta to Participate in the Baird 2022 Global Healthcare Conference (PR Newswire)
Aug-30-22 04:05PM	Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (PR Newswire)
Aug-11-22 04:05PM	Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (PR Newswire)
09:21AM	Is It Too Late To Consider Buying Azenta, Inc. (NASDAQ:AZTA)? (Simply Wall St.)
Aug-09-22 04:20PM	Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022 (PR Newswire) -7.48%
Aug-08-22 04:05PM	Azenta Announces Agreement to Acquire B Medical Systems (PR Newswire)
01:58PM	Top Stocks for August 2022 (Investopedia)
Aug-05-22 04:05PM	Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit (PR Newswire)
Jul-27-22 04:05PM	Azenta Celebrates Opening of New China Headquarters (PR Newswire)
Jul-13-22 04:05PM	Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022 and Announces Earnings Conference Call and Webcast (PR Newswire) -16.71%
Jul-01-22 04:05PM	Azenta Announces Completion of Barkey Holding GmbH Acquisition (PR Newswire)
Jun-29-22 12:06PM	Top Healthcare Stocks for July 2022 (Investopedia)
Jun-08-22 06:30AM	Azenta Announces Agreement to Acquire Barkey Holding GmbH (PR Newswire)
Jun-02-22 04:05PM	Azenta to Participate in the Jefferies Healthcare Conference (PR Newswire)
May-19-22 08:00AM	Azenta to Participate in the UBS Global Healthcare Conference (PR Newswire)
May-06-22 03:25PM	Investors in Azenta (NASDAQ:AZTA) have made a strong return of 178% over the past five years (Simply Wall St.)

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pirogova Olga	SVP and CHRO	Nov 19 '24	Sale	40.07	548	21,958	19,373	Nov 21 04:10 PM
Hughes Violetta	VP, Chief Accounting Officer	Nov 19 '24	Sale	40.07	163	6,531	9,920	Nov 21 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Nov 19 '24	Sale	40.07	491	19,674	27,499	Nov 21 04:10 PM
Wang David Dong	SVP & GM, SMS	Nov 19 '24	Sale	40.07	348	13,944	24,114	Nov 21 04:10 PM
Joseph Jason	SVP, General Counsel, Secy.	Nov 19 '24	Sale	40.07	1,139	45,640	112,564	Nov 21 04:10 PM
Cueto Herman	EVP, Chief Financial Officer	Nov 19 '24	Sale	40.07	712	28,530	23,892	Nov 21 04:10 PM
Marotta John	President and CEO	Nov 18 '24	Buy	39.48	12,717	502,066	99,612	Nov 19 04:10 PM
Marotta John	President and CEO	Nov 19 '24	Buy	40.67	1,250	50,838	100,862	Nov 19 04:10 PM
Cornog William L	Director	Nov 18 '24	Buy	39.60	12,500	495,000	14,755	Nov 19 04:10 PM
HIRSCH DIDIER	Director	Nov 18 '24	Buy	39.50	1,000	39,500	3,465	Nov 19 04:10 PM
Madaus Martin D	Director	Nov 19 '24	Buy	40.77	4,940	201,404	7,405	Nov 19 04:00 PM
Cueto Herman	EVP, Chief Financial Officer	Oct 17 '24	Sale	43.68	1,595	69,670	24,604	Oct 21 04:10 PM
JASON JOSEPH	Officer	Aug 01 '24	Proposed Sale	62.05	1,000	62,050		Aug 01 04:26 PM

Dollar change +0.82
Percentage change 0.58	%

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: IJH VTI VB VXF VBK MDY IBB IJK FBT SPMD

Index	-	P/E	-	EPS (ttm)	-0.15	Insider Own	6.98%	Shs Outstand	55.77M	Perf Week	14.31%
Market Cap	8.03B	Forward P/E	80.68	EPS next Y	1.77	Insider Trans	-1.34%	Shs Float	52.12M	Perf Month	5.47%
Income	-8.10M	PEG	-	EPS next Q	0.41	Inst Own	99.78%	Short Float	6.33%	Perf Quarter	-2.78%
Sales	633.51M	P/S	12.68	EPS this Y	-11.95%	Inst Trans	-1.27%	Short Ratio	4.69	Perf Half Y	-9.85%
Book/sh	36.00	P/B	3.96	EPS next Y	14.69%	ROA	-0.30%	Short Interest	3.30M	Perf Year	-11.00%
Cash/sh	13.91	P/C	10.25	EPS next 5Y	21.00%	ROE	-0.41%	52W Range	113.50 - 211.13	Perf YTD	-20.70%
Dividend Est.	-	P/FCF	61.22	EPS past 5Y	11.56%	ROI	-0.30%	52W High	-32.47%	Beta	0.95
Dividend TTM	-	Quick Ratio	8.76	Sales past 5Y	31.26%	Gross Margin	45.74%	52W Low	25.62%	ATR (14)	7.27
Dividend Ex-Date	-	Current Ratio	10.44	EPS Y/Y TTM	-108.02%	Oper. Margin	4.39%	RSI (14)	52.98	Volatility	5.05% 4.92%
Employees	1783	Debt/Eq	0.33	Sales Y/Y TTM	-2.91%	Profit Margin	-1.28%	Recom	1.53	Target Price	193.08
Option/Short	Yes / Yes	LT Debt/Eq	0.33	EPS Q/Q	-103.94%	Payout	0.00%	Rel Volume	0.79	Prev Close	141.76
Sales Surprise	-1.47%	EPS Surprise	28.21%	Sales Q/Q	9.69%	Earnings	Nov 12 BMO	Avg Volume	703.45K	Price	142.58
SMA20	2.64%	SMA50	1.65%	SMA200	-8.43%	Trades		Volume	556,879	Change	0.58%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$241
Aug-24-20	Reiterated	H.C. Wainwright	Buy	$151 → $168
Jun-30-20	Reiterated	H.C. Wainwright	Buy	$143 → $151
May-07-20	Reiterated	H.C. Wainwright	Buy	$100 → $143
Mar-23-20	Reiterated	H.C. Wainwright	Buy	$110 → $100
Nov-15-19	Initiated	Stifel	Buy
Nov-01-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$107 → $110
Oct-15-19	Initiated	SVB Leerink	Outperform	$100

Show Previous Ratings

Nov-13-24 09:54AM	Analyst Report: Repligen Corporation (Morningstar Research)
02:37AM	Q3 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
02:08AM	Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-24 11:55AM	Repligen Stock Soars 10% on Record Growth and Bold Moves (GuruFocus.com) +6.51%
09:05AM	Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	Loading…
08:00AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:04AM	Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 07:30AM	Repligen to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 10:01AM	Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-15-24 12:45PM	3 investable themes, categories outside of the AI trade (Yahoo Finance Video)
Oct-04-24 11:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Oct-03-24 11:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
Sep-24-24 07:30AM	Repligen Opens Training & Innovation Center to Elevate Customer Experience (GlobeNewswire)
06:35AM	Loading…
Sep-11-24 06:35AM	Several Headwinds Dragged Repligen Corporation (RGEN) in Q2 (Insider Monkey)
Sep-09-24 05:20AM	Reasons for the Decline of Repligen (RGEN) in Q2 (Insider Monkey)
Sep-07-24 07:37AM	Repligen Corporation (RGEN) Fell Due to CEO Transition (Insider Monkey)
Aug-29-24 11:31AM	Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-23-24 08:43AM	Repligen Corporation (RGEN) Benefitted From Drug Approval (Insider Monkey)
07:30AM	Repligen Corporation to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-16-24 04:39AM	Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)? (Insider Monkey) -9.26%
Aug-02-24 07:09AM	Here's Why Shares in This Hot Healthcare Stock Surged This Week (Motley Fool)
Jul-31-24 10:46AM	Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates (Zacks)
12:30AM	Q2 2024 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 08:45AM	Repligen (RGEN) Q2 Earnings Meet Estimates (Zacks) +16.37%
07:45AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:55AM	Should You Consider Investing in Repligen Corporation (RGEN)? (Insider Monkey)
Jul-29-24 04:00PM	Repligen Announces Agreement to Acquire Chromatography Innovator Tantti (GlobeNewswire)
10:01AM	Loading…
Jul-23-24 10:01AM	Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-20-24 08:21AM	Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now? (Insider Monkey)
Jul-16-24 07:30AM	Repligen to Report Second Quarter 2024 Financial Results (GlobeNewswire) +10.11%
Jun-24-24 07:33AM	Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock? (Zacks)
Jun-15-24 02:50AM	Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN) (GuruFocus.com)
02:50AM	Director Nicolas Barthelemy Acquires 1,200 Shares of Repligen Corp (RGEN) (GuruFocus.com)
Jun-14-24 11:43AM	Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change (Zacks)
Jun-13-24 07:00AM	Repligen Announces CEO Transition Plan (GlobeNewswire) -11.85%
Jun-03-24 08:00AM	Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing (Business Wire)
May-31-24 11:31AM	Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-23-24 02:12AM	Insider Sell: CEO Anthony Hunt Sells 20,072 Shares of Repligen Corp (RGEN) (GuruFocus.com)
May-22-24 07:30AM	Repligen Corporation to Present at Upcoming June Investor Conferences (GlobeNewswire)
May-15-24 09:53AM	Here's Why Baron Discovery Fund Sold Repligen Corporation (RGEN) (Insider Monkey)
May-07-24 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-24 11:31AM	UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating (MT Newswires) +5.02%
11:31AM	Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:23AM	Repligen (RGEN) Q1 Earnings Miss, Revenues Beat Estimates (Zacks)
03:06AM	Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Shifts and ... (GuruFocus.com)
May-01-24 11:53AM	RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:11AM	Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment with Analyst Projections (GuruFocus.com)
08:50AM	Repligen (RGEN) Misses Q1 Earnings Estimates (Zacks)
08:47AM	Repligen's Q1 Adjusted Earnings, Revenue Fall (MT Newswires)
07:47AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-23-24 11:43AM	Should be Confident in Repligen Corporation (RGEN)'s Long-Term Growth Potential? (Insider Monkey) +8.76%
Apr-17-24 07:30AM	Repligen to Report First Quarter 2024 Financial Results (GlobeNewswire)
Apr-12-24 10:07AM	Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation (Insider Monkey)
09:49AM	Should You Sell Pool Corporation (POOL)? (Insider Monkey)
Mar-19-24 07:30AM	Repligen Appoints Maggie A. Pax to Board of Directors (GlobeNewswire)
Mar-12-24 01:18AM	Repligen Corp CEO Anthony Hunt Sells 16,707 Shares (GuruFocus.com)
Feb-27-24 02:02AM	Repligen Corp COO James Bylund Sells 4,373 Shares (GuruFocus.com)
Feb-24-24 12:03AM	Decoding Repligen Corp (RGEN): A Strategic SWOT Insight (GuruFocus.com)
Feb-22-24 11:24AM	Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:39AM	Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/Y (Zacks)
Feb-21-24 08:45AM	Repligen (RGEN) Lags Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Repligen Corp (RGEN) Reports Decline in 2023 Revenue and Net Income (GuruFocus.com)
07:51AM	Repligen: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-07-24 07:30AM	Repligen to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-31-24 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-29-24 05:09AM	Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength? (Zacks)
Dec-19-23 07:30AM	Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 04:49AM	Here's Why Repligen Corporation (RGEN) Rose 13% in Q3 (Insider Monkey)
Dec-07-23 07:30AM	Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements (GlobeNewswire)
Nov-30-23 11:31AM	Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-15-23 07:15AM	Does Repligen Corp. (RGEN) Have a Bright Future? (Insider Monkey)
Nov-14-23 02:01PM	UPDATE Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire) +5.55%
07:30AM	Repligen Announces Publication of the Company's 2022 Sustainability Report (GlobeNewswire)
Nov-07-23 07:30AM	Repligen Corporation to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 07:30AM	Repligen Launches TangenX SC as First-to-Market Holder-Free Self-Contained TFF Device (GlobeNewswire)
Nov-01-23 12:10PM	Repligen Corporation (NASDAQ:RGEN) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:46AM	Repligen (RGEN) Shares Rise on Q3 Earnings & Revenue Beat (Zacks)
12:04AM	Q3 2023 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-31-23 09:41AM	Repligen Corp (RGEN) Reports Q3 2023 Earnings: Revenue Down 30% Y/Y (GuruFocus.com) +17.86%
09:12AM	Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outlook (RTT News)
08:50AM	Repligen (RGEN) Tops Q3 Earnings and Revenue Estimates (Zacks)
07:41AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-25-23 10:01AM	Analysts Estimate Exelixis (EXEL) to Report a Decline in Earnings: What to Look Out for (Zacks) -10.99%
Oct-24-23 10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-17-23 11:44AM	Repligen (RGEN)'s Hidden Value: An In-Depth Analysis of Its Market Worth (GuruFocus.com)
07:30AM	Repligen to Report Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-02-23 07:30AM	Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer (GlobeNewswire)
Sep-27-23 06:51AM	Repligen (RGEN) to Acquire Fluid Management Company Metenova (Zacks)
Sep-26-23 12:41PM	Waltham's Repligen to acquire Swedish firm (American City Business Journals)
07:30AM	Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova (GlobeNewswire)
Sep-14-23 10:10AM	Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains? (Zacks)
Sep-12-23 07:30AM	Repligen Appoints Jason K. Garland as Chief Financial Officer (GlobeNewswire)
Sep-06-23 03:06AM	Reasons For the Decline of Repligen Corporation (RGEN) (Insider Monkey)
Sep-01-23 12:19PM	Drug Developer Stocks Are Risky. Why a Picks-and-Shovels Approach Makes Sense. (Barrons.com)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Anthony	Director	Nov 21 '24	Option Exercise	33.87	24,246	821,212	164,086	Nov 22 04:52 PM
Hunt Anthony	Director	Nov 21 '24	Sale	139.67	24,246	3,386,439	139,840	Nov 22 04:52 PM
Anthony Hunt	Executive Chairman	Nov 21 '24	Proposed Sale	139.66	24,246	3,386,311		Nov 21 03:52 PM
MUIR GLENN P	Director	Nov 19 '24	Option Exercise	36.29	19,000	689,510	32,283	Nov 20 02:29 PM
Hunt Anthony	Director	Sep 10 '24	Option Exercise	33.87	10,000	338,700	162,031	Sep 12 11:35 AM
Hunt Anthony	Director	Sep 10 '24	Sale	145.37	22,191	3,225,927	139,840	Sep 12 11:35 AM
Hunt Anthony	Officer	Sep 10 '24	Proposed Sale	144.72	22,191	3,211,481		Sep 10 04:03 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Option Exercise	86.10	175	15,067	12,463	Aug 05 09:56 PM
KURIYEL RALF	Senior VP, R&D	Aug 02 '24	Sale	159.35	7,148	1,139,016	12,288	Aug 05 09:56 PM
Ralf Kuriyel	Senior Vice President	Aug 02 '24	Proposed Sale	159.35	7,148	1,139,040		Aug 02 03:26 PM
KURIYEL RALF	Senior VP, R&D	Aug 01 '24	Sale	165.67	4,465	739,717	19,261	Aug 01 08:47 PM
MUIR GLENN P	Director	Aug 01 '24	Option Exercise	36.29	5,000	181,450	13,283	Aug 01 05:04 PM
Christine Gebski	Senior Vice President	Aug 01 '24	Proposed Sale	167.00	2,160	360,720		Aug 01 04:11 PM
Ralf Kuriyel	Senior Vice President	Aug 01 '24	Proposed Sale	165.67	4,465	739,705		Aug 01 04:07 PM
Madaus Martin D	Director	Jun 14 '24	Buy	124.94	1,615	201,776	4,613	Jun 14 06:07 PM
BARTHELEMY NICOLAS	Director	Jun 14 '24	Buy	125.45	1,200	150,540	4,668	Jun 14 05:42 PM
Hunt Anthony	Chief Executive Officer	Jun 14 '24	Buy	124.08	2,000	248,160	165,177	Jun 14 05:41 PM
DAWES KAREN A	Director	Jun 14 '24	Option Exercise	67.71	2,953	199,948	88,170	Jun 14 05:33 PM
Hunt Anthony	Chief Executive Officer	May 21 '24	Sale	168.26	20,072	3,377,283	163,177	May 22 05:14 PM
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Option Exercise	86.10	1,271	109,433	27,777	Mar 12 08:24 PM
KURIYEL RALF	Senior VP, R&D	Mar 11 '24	Sale	193.73	3,517	681,348	24,260	Mar 12 08:24 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Option Exercise	16.55	1	17	201,956	Mar 11 07:43 PM
Hunt Anthony	Chief Executive Officer	Mar 08 '24	Sale	197.44	16,707	3,298,632	185,249	Mar 11 07:43 PM
DAWES KAREN A	Director	Feb 27 '24	Option Exercise	42.07	4,626	194,616	88,367	Feb 28 09:56 PM
DAWES KAREN A	Director	Feb 27 '24	Sale	193.35	1,000	193,350	87,367	Feb 28 09:56 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Option Exercise	94.33	940	88,670	18,508	Feb 26 08:38 PM
Bylund James	Chief Operating Officer	Feb 23 '24	Sale	198.08	4,373	866,204	14,135	Feb 26 08:38 PM

AZTA

Azenta Inc

RGEN

Repligen Corp

Upgrade your FINVIZ experience